. .

Request Information

Would you like information on our Certification and Education programs?

To access our online Request Form: click here

Visit our Web Site

AIHCP.ORG

access here

Grief Counseling Articles & Discussion

AIHCP Magazine, Articles, Discussions

Access Archive Posts

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers

case management

Last Tweets

Bereavement Counseling Training Program Article on Antidepressants and Depression

Good article about the dangers of suicide and anti-depressants and who is responsible

Antidepressants and depression, a connection? Please also review our bereavement counseling training program.

Antidepressants and depression, a connection? Please also review our bereavement counseling training program.

Please also review our Bereavement Counseling Training Program to learn how to help people navigate the phases of grief itself via natural coping methods

The article, Lawsuit Over a Suicide Points to a Risk of Antidepressants, by RONI CARYN RABIN states

“The last dinner Wendy Dolin had with her husband, Stewart, he was so agitated that he was jiggling his leg under the table and could barely sit still. He had recently started a new antidepressant but still felt very anxious. “I don’t get it, Wen,” he said.

The next day, Mr. Dolin, a 57-year-old Chicago lawyer, paced up and down a train platform for several minutes and then threw himself in front of an oncoming train.

Ms. Dolin soon became convinced that the drug her husband had started taking five days before his death — paroxetine, the generic form of Paxil — played a role in his suicide by triggering a side effect called akathisia, a state of acute physical and psychological agitation. Sufferers have described feeling as if they were “jumping out of their skin.”

The distress of akathisia may explain the heightened risk of suicide in some patients, some psychiatrists believe. The symptoms are so distressing, a drug company scientist wrote in the Journal of Psychopharmacology, that patients may feel “death is a welcome result.”

Ms. Dolin sued the original manufacturer of Paxil, GlaxoSmithKline, claiming the company had not sufficiently warned of the risks associated with the drug. In April, a jury awarded Ms. Dolin $3 million in damages.”

To read the entire article, please click here

Please also review our Bereavement Counseling Training Program

Leave a Reply